The U.S. Food and Drug Administration is taking a drastic step over a common drug used to treat allergies and acid reflux, following an investigation that confirmed the persistent presence of a likely carcinogen in products containing it. On Wednesday, the agency announced that it’s requesting all manufacturers of ranitidine…
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.